Gut infection test gets FDA go-ahead

BD Diagnostics, of Sparks, a segment of Becton, Dickinson & Co., a global medical technology company, announced it has received U.S. Food and Drug Administration clearance to market the BD MAX Cdiff Assay in the United States.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


Scroll To Top